• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

PARP inhibitor

Biotech

Roche pays Repare $125M to join Big Pharma peers in cancer race

Roche is joining AstraZeneca, Bayer, Merck KGaA and more in a synthetic lethality race, paying $125 million upfront for an ATR inhibitor.
Nick Paul Taylor Jun 2, 2022 8:27am

AstraZeneca re-ups ties with Chinese cancer test maker AmoyDx

Apr 18, 2022 10:42am

Ribon raises $65M to take PARP7 inhibitor deeper into the clinic

Jul 14, 2021 8:20am

Combating BRCA-mutated tumors via a new pathway

Jun 17, 2021 11:00am

Valo to go public via Khosla-backed SPAC, gaining $500M-plus

Jun 10, 2021 4:11am

AACR: Zentalis' WEE1 inhibitor shows promise in phase 1

Apr 10, 2021 1:30pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy